The AgentShield runtime interception layer — which enforces least-privilege tool access and prompt injection detection without requiring model fine-tuning — is a technically defensible moat. Acquirers classify this as a capability buy, not a talent buy. Three of your top six acquirer matches have cited similar capability descriptions in recent earnings calls and analyst briefings.

Cloud security platforms with large enterprise installed bases — Wiz, Orca, Lacework — are your highest-leverage partnership targets. They have the distribution and the customer relationships; you have the agentic runtime capability they cannot build fast enough. Co-sell arrangements with one Tier 1 CSPM vendor could represent a 3–5× ARR multiplier within 18 months.

Growth investors see a category-defining moment with regulatory tailwinds — the EU AI Act's agent accountability provisions and upcoming NIST AI RMF updates create compliance mandates that convert your platform from a best-practice tool to a procurement requirement. The seed-to-Series B arc is clearly scoped; the narrative risk is whether the market moves fast enough to match your burn rate.

ARR below $3M puts NeuralGuard below the typical acquisition threshold for the largest platforms — though strategic acquirers are known to move early for category-defining tools. Customer concentration (top 2 accounts = 48% of ARR) is a diligence risk. Lack of published incident response case studies weakens the proof-of-value story for enterprise security buyers.